phorbol-12-myristate has been researched along with bryostatin 1 in 2 studies
| Studies (phorbol-12-myristate) | Trials (phorbol-12-myristate) | Recent Studies (post-2010) (phorbol-12-myristate) | Studies (bryostatin 1) | Trials (bryostatin 1) | Recent Studies (post-2010) (bryostatin 1) |
|---|---|---|---|---|---|
| 128 | 0 | 79 | 727 | 46 | 174 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazanietz, MG; von Burstin, VA; Xiao, L | 1 |
| Baumann, DO; Blumberg, PM; Cataisson, C; Chen, J; Herrmann, MA; Keck, GE; Kelsey, JS; McGowan, KM; Petersen, ME; Yuspa, SH | 1 |
2 other study(ies) available for phorbol-12-myristate and bryostatin 1
| Article | Year |
|---|---|
Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
Topics: Antineoplastic Agents; Apoptosis; Bryostatins; Humans; Isoenzymes; Lactones; Male; Phorbol Esters; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-delta; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2010 |
Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
Topics: Animals; Antineoplastic Agents; Bryostatins; Drug Design; Epidermis; Female; Keratinocytes; Mice, Inbred BALB C; Mice, Inbred SENCAR; Phorbol Esters; Protein Kinase C; Skin Neoplasms | 2016 |